Artificial Oocyte Activation Comparing Tow Different Agents
NCT ID: NCT02424214
Last Updated: 2018-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
450 participants
INTERVENTIONAL
2015-04-30
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Novel Approach With Double Agent Artificial Oocyte Activation for Repeated Fertilization Failure Due to Combined Sperm and Oocyte Factor
NCT02418416
Effect of Ca2+ Ionophore on Embryonic Development and Clinical Outcome in Cases With Previous Fertilization Arrest
NCT02683031
Oocyte Vitrification Aided With Latrunculin A
NCT03678571
Polar Body Removal Before ICSI for Oocyte Activation in Previous Fertilization Failure Cases
NCT02913781
Efficacy of Oocyte Activation With Two Types of Ca2+ Ionophore.
NCT06106412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ca Ionophore group
Artificial Oocyte activation with Ca Ionophore for 20 min after Intracytoplasmic Sperm Injection
Artificial Oocyte activation
Ca Ionophore
Strontium Chloride group
Artificial Oocyte activation with Strontium Chloride for 60 min after Intracytoplasmic Sperm Injection
Artificial Oocyte activation
Strontium Chloride
Only Intracytoplasmic Sperm Injection
after Intracytoplasmic Sperm Injection Oocytes will cultured and incubated
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Artificial Oocyte activation
Ca Ionophore
Strontium Chloride
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* poor quality Oocytes
* poor sperms
Exclusion Criteria
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al Baraka Fertility Hospital
OTHER
Banon IVF Center Assiut, Egypt
OTHER
Ibn Sina Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Fawzy
IVF Lab Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Al Barka fertility center
Manama, , Bahrain
Banon Fertility Center
Asyut, , Egypt
Ibnsina IVF center
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fawzy M, Emad M, Mahran A, Sabry M, Fetih AN, Abdelghafar H, Rasheed S. Artificial oocyte activation with SrCl2 or calcimycin after ICSI improves clinical and embryological outcomes compared with ICSI alone: results of a randomized clinical trial. Hum Reprod. 2018 Sep 1;33(9):1636-1644. doi: 10.1093/humrep/dey258.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IbnSina Oocyte activation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.